Results
13
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
13 companies
Shree Ganesh Remedies
Market Cap: ₹9.0b
Engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India.
540737
₹702.85
7D
-1.0%
1Y
11.7%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹465.4b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,747.05
7D
0.4%
1Y
45.8%
NATCO Pharma
Market Cap: ₹138.9b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹775.50
7D
-2.7%
1Y
-20.4%
Torrent Pharmaceuticals
Market Cap: ₹1.1t
Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,127.50
7D
-4.8%
1Y
21.4%
Gujarat Terce Laboratories
Market Cap: ₹460.7m
Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.
524314
₹62.08
7D
-1.5%
1Y
12.8%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.0b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹210.72
7D
-2.4%
1Y
79.5%
Nirman Agri Genetics
Market Cap: ₹1.6b
Operates as an agri-input company in India.
NIRMAN
₹264.50
7D
13.0%
1Y
28.4%
Ind-Swift Laboratories
Market Cap: ₹5.0b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹83.83
7D
-2.5%
1Y
-35.5%
Jeena Sikho Lifecare
Market Cap: ₹56.4b
Trades in ayurvedic medicines in India.
JSLL
₹2,269.45
7D
8.7%
1Y
109.7%
Sanjivani Paranteral
Market Cap: ₹2.8b
Operates as a pharmaceutical company in India.
531569
₹234.05
7D
-5.1%
1Y
55.3%
Abbott India
Market Cap: ₹628.5b
Operates as a pharmaceutical company in India.
500488
₹29,578.60
7D
1.8%
1Y
11.8%
Caplin Point Laboratories
Market Cap: ₹142.1b
Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.
524742
₹1,869.40
7D
-3.5%
1Y
44.5%
Beta Drugs
Market Cap: ₹18.7b
Develops, manufactures, and sells anti-cancer drugs in India.
BETA
₹1,850.00
7D
-2.5%
1Y
49.2%